Create New Account Purchaser Login
Search Tenders
Search
Advanced Search
You are not logged in.

Future Procurement Opportunity (FPO) – Supply of permanent coronary drug eluting stents under a market share arrangement

Details

RFx ID : 25197649
Tender Name : Future Procurement Opportunity (FPO) – Supply of permanent coronary drug eluting stents under a market share arrangement
Reference # : A1546689
Open Date : Q4 2021
Indicative RFx Release Date  : Q1 2022  [?]
Tender Type : Future Procurement Opportunity (FPO)
Project Status : Confirmed  [?]
Indicative Total Value : $10M - $25M  [?]
Expected number of contracts offered : 1
 
Categories :
  • 42000000 - Medical Equipment and Accessories and Supplies
Regions:
  • New Zealand
Required Pre-qualifications : None
Contact : Pharmac Procurement Team
procurement@pharmac.govt.nz
Overview

Pharmac is planning on issuing a competitive process for supply of permanent coronary drug eluting stents under a market share arrangement. Pharmac currently has a market share arrangement in place for permanent coronary drug eluting stents for a single supplier with a 65% minimum market share.

The approximate gross annual expenditure of all permanent coronary drug eluting stents in the 2020/21 FYR was $6,572,000. Under the current market share DHB hospitals are expected to use the successful supplier for a minimum of 65% of their usage.

Further detail and notification of approval of the current market share arrangement is available here: https://pharmac.govt.nz/hospital-devices/whats-happening-in-each-category/permanent-coronary-drug-eluting-stents/.

Pharmac would hold a supplier briefing in relation to this procurement process once the RFP has been released. Further information would be available on the Pharmac website for suppliers to pre-register.